Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5363317 | 0.81 | CYP1A2 (0.36) | PKMALDH1A1NPSR1MAPT | |
| SCHEMBL5160782 | 0.80 | PKM (0.36) | PKMALDH1A1NPSR1HSD17B10ADORA3 | |
| SCHEMBL5158190 | 0.76 | NPSR1 (0.33) | PKMALDH1A1NPSR1HSD17B10ADORA3 | |
| SCHEMBL11511635 | 0.70 | POLB (0.34) | PKMALDH1A1NPSR1HSD17B10LMNA | |
| SCHEMBL4616219 | 0.68 | PKM (0.35) | PKMALDH1A1NPSR1HSD17B10LMNA | |
| SCHEMBL11875470 | 0.68 | POLB (0.38) | PKMALDH1A1NPSR1HSD17B10LMNA | |
| SCHEMBL11439707 | 0.67 | TSHR (0.36) | ALDH1A1NPSR1LMNATSHRHTT | |
| SCHEMBL11759567 | 0.67 | PKM (0.38) | PKMALDH1A1NPSR1HSD17B10LMNA | |
| SCHEMBL6253709 | 0.65 | PKM (0.32) | PKMALDH1A1NPSR1TSHR | |
| SCHEMBL11528939 | 0.65 | NPSR1 (0.38) | PKMALDH1A1NPSR1HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166621-B2 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA LIMITED (GB) | 2007-01-23 | — | — | US | disclosed |
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | DDT, C3AR1, CNPY3 | PKM 3859/4885ALDH1A1 1815/4885NPSR1 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.